Clinical Trial Update: A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase 1 study of KK4277 in healthy volunteers and patients with systemic lupus erythematosus and cutaneous lupus erythematosus; the trial is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Systemic Lupus Erythematosus

Drugs mentioned

• KK4277

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Healthy Volunteers, Systemic Lupus Erythematosus (SLE) | Phase 1 | Status: ACTIVE_NOT_RECRUITING